Skip to main content
. 2018 Feb 23;16(2):e05172. doi: 10.2903/j.efsa.2018.5172

Table A.1.

Summary of data used for derivation of benchmark doses for megalocytic hepatocytes and hepatic apoptosis (Bondy et al., 2012)

Doses in mg/kg bw per day Individual scores megalocytic hepatocytes (cut off = 1) Combined incidence megalocytic hepatocytes (WT and TG) Individual scores Apoptosis (cut off = 2) Combined incidence apoptosis (WT and TG)

0 (WT)

0 (TG)

0 0 0 0 0 0 0 0 0 (WT)

0 0 0 0 0 0 0 0 0 0 (TG)

0/19

1 1 1 1 1 1 1 1 1 (WT)

1 1 1 1 1 1 1 1 1 1 (TG)

0/19

0.39 (WT)

0.37 (TG)

0 0 0 0 0 0 1 0 2 0 (WT)

0 0 1 0 0 0 0 0 1 0 (TG)

4/20

1 1 1 1 1 1 1 1 1 1 (WT)

1 1 1 1 1 1 1 1 1 1 (TG)

0/20

3.87 (WT)

3.88 (TG)

1 0 2 1 0 0 1 0 1 (WT)

2 2 2 0 0 0 0 1 0 0 (TG)

9/19

4 3 4 4 2 2 2 1 3 (WT)

4 3 4 3 3 5 1 2 4 3 (TG)

17/19

12.2 (WT)

12.6 (TG)

5 5 5 5 4 3 3 5 5 5 (WT)

5 5 5 5 5 5 5 0 5 5 (TG)

19/20

4 4 4 5 5 5 3 4 5 5 (WT)

4 3 3 4 4 4 4 3 5 5 (TG)

20/20

WT: WG strain; TG: TG strain.

Note: for explanation of pathology scoring see Section 10.2.7.